Mutagenic and genotoxic effect of hydroxyurea
Carregando...
Data
2011-12-15
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
The hydroxyurea, a cytotoxic drug, is the mainly available therapeutical strategy for the treatment of sickle cell disease. This study aimed to evaluate the mutagenic and genotoxic potential of the hydroxyurea through the Salmonella/Microsome assay and micronucleus test in peripheral blood of mice. The doses were evaluated at 29.25-468 μmol/plate in Salmonella/Microsome assay in presence and absence of metabolic activation the drug. In the micronucleus test the doses were evaluated at 12.5; 25; 50; 75 and 100 mg/kg. The results show that hydroxyurea present mutagenic activity in TA98 and TA100 in doses above 117 μmol/plate and 234 μmol/plate respectively. The drug induced a significant increase in the frequency of micronuclei in reticulocytes of mice at concentrations of 50, 75 and 100 mg/kg, compared to negative control (water). These results demonstrated the mutagenic and genotoxic potential of hydroxyurea. © 2011 Santos et al.
Descrição
Palavras-chave
Genotoxicity, Hydroxyurea, Micronucleus test, Mutagenicity, cyclophosphamide, hydroxyurea, water, animal cell, animal experiment, animal model, bacterial strain, blood analysis, controlled study, drug blood level, drug dose comparison, female, genotoxicity, male, metabolic activation, micronucleus test, microsome, mouse, mutagenicity, nonhuman, reticulocyte count, Salmonella typhimurium, concentration response, drug effect, mutagenic activity, toxicity testing, Mus
Idioma
Inglês
Como citar
International Journal of Biomedical Science, v. 7, n. 4, 2011.